KZIA NASDAQ
Kazia Therapeutics Ltd ADR
1W: -3.1%
1M: -26.5%
3M: -29.1%
YTD: +85.4%
1Y: +35.3%
3Y: -82.0%
5Y: -98.3%
$9.27
-0.20 (-2.11%)
Weekly Expected Move ±9.3%
$8
$8
$9
$10
$11
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$13M
-38.6% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$13M
-38.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3M
+175.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$25M | -$20M | -$27M | -$21M |
| Depreciation & Amort. | $1M | $2M | $2M | $2M | $934K |
| Stock-Based Comp. | $637K | $2M | $1M | $533K | $653K |
| Change in Working Capital | -$6M | $862K | $4M | $10M | -$3M |
| Other Non-Cash Items | $3M | -$2M | -$2M | $5M | $9M |
| Operating Cash Flow | -$9M | -$23M | -$15M | -$10M | -$13M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | -$2M | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$2M | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $405K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $1M |
| Financing Cash Flow | $28M | $4M | $13M | $6M | $16M |
| Net Change in Cash | $19M | -$20M | -$2M | -$4M | $3M |
| Cash End of Period | $28M | $7M | $5M | $2M | $4M |
| Free Cash Flow | -$9M | -$23M | -$15M | -$10M | -$13M |